Endometrial Cancer Market, By Type of Cancer, By Type of Therapy, By Diagnosis Method, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

Description

REPORT HIGHLIGHT

Endometrial Cancer Market size was valued at USD 26,394.53 million in 2023, expanding at a CAGR of 5.80% from 2024 to 2032.

Endometrial cancer is a form of cancer that originates from the cellular growth within the uterus, which is the hollow, pear-shaped organ in the pelvis responsible for fetal development. In the United States, it is the most prevalent cancer impacting the reproductive system of women and individuals assigned female at birth (AFAB). This type of cancer predominantly occurs following menopause. Approximately 3% of women and individuals with AFAB will be diagnosed with uterine cancer at some stage in their lives, with around 65,000 new cases reported annually.

Endometrial Cancer Market- Market Dynamics

The increasing prevalence of endometrial cancer is anticipated to propel market expansion.

As the number of endometrial cancer cases escalates, there is an increasing demand for efficient diagnostic tools and services. This encompasses the utilization of imaging technologies, such as ultrasound and MRI, along with biopsy procedures. Improved awareness and screening practices can facilitate earlier diagnoses, which are crucial for enhancing treatment outcomes. According to the World Cancer Research Fund International, there were 420,368 new cases of endometrial cancer reported in 2022. The ongoing research and development, along with advancements in treatment modalities, may present growth opportunities for the market. However, limited access to healthcare services could hinder market growth.

Endometrial Cancer Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.80% over the forecast period (2024-2032)

Based on Type of Cancer segmentation, Endometrial Carcinoma was predicted to show maximum market share in the year 2023

Based on Type of Therapy segmentation, Chemotherapy was the leading type in 2023

Based on Diagnosis Method segmentation, Biopsy was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Endometrial Cancer Market- Segmentation Analysis:

The Global Endometrial Cancer Market is segmented on the basis of Type of Cancer, Type of Therapy, Diagnosis Method, and Region.

The market is divided into two categories based on the Type of Cancer: Endometrial Carcinoma, Uterine Sarcomas, and Others. Endometrial Carcinoma dominates the market. Endometrial carcinoma is a type of cancer that originates in the lining of the uterus (endometrium). It accounts for the majority of uterine cancers and is usually diagnosed in postmenopausal women.

The market is classified into three segments according to the Type of Therapy: Immunotherapy, Radiation Therapy, Chemotherapy, and Others. The Chemotherapy segment holds a dominant position within the market. It is widely recognized as one of the primary treatment options for advanced, recurrent, or aggressive types of endometrial cancer.

The market is segmented into four categories according to the Diagnosis Method: Biopsy, Pelvic Ultrasound, Hysteroscopy, CT scan, and others. Biopsy holds a predominant position in the market. The significance of biopsies in the early detection and diagnosis of endometrial cancer is paramount, as they directly affect treatment choices and the demand for diagnostic tools and methodologies.

Endometrial Cancer Market- Geographical Insights

North America leads the market, primarily due to advancements in diagnostic methodologies. The region is characterized by a strong healthcare system that includes numerous established cancer treatment centers and specialized facilities, all equipped with cutting-edge diagnostic technologies. This infrastructure facilitates a holistic approach to cancer care, encompassing both diagnosis and treatment. Annually, around 400,000 patients are diagnosed with cancer at NCI-Designated Cancer Centers. Europe ranks as the second largest region for market growth, attributed to heightened awareness and the implementation of screening programs. The global market is anticipated to grow further as awareness, diagnostic capabilities, and treatment alternatives continue to enhance across various regions.

Endometrial Cancer Market- Competitive Landscape:

The Endometrial Cancer Market exhibits a high level of competition, propelled by innovations in diagnostics, treatment modalities, and emerging technologies focused on enhancing patient outcomes. Numerous firms are competing for market share in sectors such as biopsy instruments, chemotherapeutic drugs, targeted therapies, and immunotherapies. Significant investments in research and development are being made to create novel treatment options, including immunotherapies, targeted therapies, and combination approaches. Advancements such as liquid biopsy and genetic testing are increasingly recognized for their potential in early detection and personalized treatment strategies. Companies that can efficiently navigate the regulatory approval process are positioned to gain a competitive edge, particularly in rapidly evolving areas like immunotherapy.

Recent Developments:

On February 5, 2024, Novartis announced that it has reached an agreement to initiate a voluntary public takeover bid for MorphoSys AG, a biopharmaceutical company based in Germany that specializes in the development of innovative oncology treatments.

A recent trial of an innovative antibody drug, which administers powerful chemotherapy directly to cancer cells, is progressing to a phase III study for patients suffering from advanced or recurrent endometrial cancer.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ENDOMETRIAL CANCER MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Pfizer Inc.
Bristol Myers Squibb Company
Merck & Co. Inc.
Novartis International AG
AstraZeneca PLC
Genentech Inc. (Roche)
GlaxoSmithKline PLC
Johnson & Johnson
Eli Lilly and Company
AbbVie Inc.
Teva Pharmaceutical Industries Ltd.
Bayer AG
Sanofi S.A.
Hoffmann-La Roche Ltd.
Exelixis Inc.
Others

GLOBAL ENDOMETRIAL CANCER MARKET, BY TYPE OF CANCER- MARKET ANALYSIS, 2019 - 2032

Endometrial Carcinoma
Uterine Sarcomas
Others

GLOBAL ENDOMETRIAL CANCER MARKET, BY TYPE OF THERAPY- MARKET ANALYSIS, 2019 - 2032

Immunotherapy
Radiation Therapy
Chemotherapy
Others

GLOBAL ENDOMETRIAL CANCER MARKET, BY DIAGNOSIS METHOD- MARKET ANALYSIS, 2019 - 2032

Biopsy
Pelvic Ultrasound
Hysteroscopy
CT scan
Others

GLOBAL ENDOMETRIAL CANCER MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

Product Code: ANV4183

1. Endometrial Cancer Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Endometrial Cancer Market Snippet by Type of Cancer
- 2.1.2. Endometrial Cancer Market Snippet by Type of Therapy
- 2.1.3. Endometrial Cancer Market Snippet by Diagnosis Method
- 2.1.4. Endometrial Cancer Market Snippet by Country
- 2.1.5. Endometrial Cancer Market Snippet by Region
2.2. Competitive Insights

3. Endometrial Cancer Key Market Trends

3.1. Endometrial Cancer Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Endometrial Cancer Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Endometrial Cancer Market Opportunities
3.4. Endometrial Cancer Market Future Trends

4. Endometrial Cancer Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Endometrial Cancer Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Endometrial Cancer Market Landscape

6.1. Endometrial Cancer Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Endometrial Cancer Market - By Type of Cancer

7.1. Overview
- 7.1.1. Segment Share Analysis, By Type of Cancer, 2023 & 2032 (%)
- 7.1.2. Endometrial Carcinoma
- 7.1.3. Uterine Sarcomas
- 7.1.4. Others

8. Endometrial Cancer Market - By Type of Therapy

8.1. Overview
- 8.1.1. Segment Share Analysis, By Type of Therapy, 2023 & 2032 (%)
- 8.1.2. Immunotherapy
- 8.1.3. Radiation Therapy
- 8.1.4. Chemotherapy
- 8.1.5. Others

9. Endometrial Cancer Market - By Diagnosis Method

9.1. Overview
- 9.1.1. Segment Share Analysis, By Diagnosis Method, 2023 & 2032 (%)
- 9.1.2. Biopsy
- 9.1.3. Pelvic Ultrasound
- 9.1.4. Hysteroscopy
- 9.1.5. CT scan
- 9.1.6. Others

10. Endometrial Cancer Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Endometrial Cancer Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Endometrial Cancer Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Endometrial Cancer Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Endometrial Cancer Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Endometrial Cancer Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Endometrial Cancer Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. Pfizer Inc.
- 11.2.2. Bristol Myers Squibb Company
- 11.2.3. Merck & Co. Inc.
- 11.2.4. Novartis International AG
- 11.2.5. AstraZeneca PLC
- 11.2.6. Genentech Inc. (Roche)
- 11.2.7. GlaxoSmithKline PLC
- 11.2.8. Johnson & Johnson
- 11.2.9. Eli Lilly and Company
- 11.2.10. AbbVie Inc.
- 11.2.11. Teva Pharmaceutical Industries Ltd.
- 11.2.12. Bayer AG
- 11.2.13. Sanofi S.A.
- 11.2.14. Hoffmann-La Roche Ltd.
- 11.2.15. Exelixis Inc.
- 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us